Patents by Inventor Elizabeth Trehu

Elizabeth Trehu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210322515
    Abstract: In part, the disclosure relates to methods of treating fibrotic cancers by administering one or more Serum Amyloid Protein (SAP) agonists. In certain aspects, the method further comprises the conjoint administration of an anti-cancer therapeutic, e.g., a chemotherapeutic agent. In certain aspects, the disclosure relates to methods of treating myelofibrosis by administering an SAP agonist and optionally one or more anti-cancer therapeutic agents.
    Type: Application
    Filed: April 27, 2021
    Publication date: October 21, 2021
    Inventors: Suzanne Bruhn, Elizabeth Trehu, Mark Lupher, Jr.
  • Patent number: 11020451
    Abstract: In part, the disclosure relates to methods of treating fibrotic cancers by administering one or more Serum Amyloid Protein (SAP) agonists. In certain aspects, the method further comprises the conjoint administration of an anti-cancer therapeutic, e.g., a chemotherapeutic agent. In certain aspects, the disclosure relates to methods of treating myelofibrosis by administering an SAP agonist and optionally one or more anti-cancer therapeutic agents.
    Type: Grant
    Filed: October 8, 2014
    Date of Patent: June 1, 2021
    Assignee: PROMEDIOR, INC.
    Inventors: Suzanne Bruhn, Elizabeth Trehu, Mark Lupher, Jr.
  • Publication number: 20180318303
    Abstract: In part, the disclosure relates to methods of treating myeloproliferative disorders by administering one or more Serum Amyloid Protein (SAP) proteins. In certain aspects, the method further comprises monitoring treatment efficacy by measuring change in mutant allele burden. In certain aspects, the disclosure relates to methods of treating myelofibrosis in patient sub-populations who carry myelofibrosis-associated mutations in some of their cells by administering an SAP protein.
    Type: Application
    Filed: April 15, 2016
    Publication date: November 8, 2018
    Inventors: Elizabeth Trehu, Richard M. Jack
  • Publication number: 20160235812
    Abstract: In part, the disclosure relates to methods of treating fibrotic cancers by administering one or more Serum Amyloid Protein (SAP) agonists. In certain aspects, the method further comprises the conjoint administration of an anti-cancer therapeutic, e.g., a chemotherapeutic agent. In certain aspects, the disclosure relates to methods of treating myelofibrosis by administering an SAP agonist and optionally one or more anti-cancer therapeutic agents.
    Type: Application
    Filed: October 8, 2014
    Publication date: August 18, 2016
    Inventors: Suzanne Bruhn, Elizabeth Trehu, Mark Lupher